BIOCRYST PHARMACEUTICALS INC Annual Interest Expense in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Biocryst Pharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from 2011 to 2023.
  • Biocryst Pharmaceuticals Inc Interest Expense for the quarter ending June 30, 2024 was $24.7M, a 14.5% decline year-over-year.
  • Biocryst Pharmaceuticals Inc Interest Expense for the twelve months ending June 30, 2024 was $101M, a 5.93% decline year-over-year.
  • Biocryst Pharmaceuticals Inc annual Interest Expense for 2023 was $108M, a 9.23% increase from 2022.
  • Biocryst Pharmaceuticals Inc annual Interest Expense for 2022 was $99.1M, a 67.1% increase from 2021.
  • Biocryst Pharmaceuticals Inc annual Interest Expense for 2021 was $59.3M, a 309% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $108M +$9.15M +9.23% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $99.1M +$39.8M +67.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $59.3M +$44.8M +309% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $14.5M +$2.61M +21.9% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-27
2019 $11.9M +$2.72M +29.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $9.18M +$611K +7.13% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-01
2017 $8.57M +$2.08M +32% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-13
2016 $6.49M +$1.29M +24.8% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 $5.2M +$202K +4.04% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-12
2014 $5M +$220K +4.6% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
2013 $4.78M +$112K +2.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
2012 $4.67M +$892K +23.6% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 $3.77M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.